Extracellular TRAP activity, indicative of osteoclast activity, was elevated in PJI compared to the control group, especially following PD-L1 treatment (3.781 vs 1.995 mU/mL, p < 0.001; Fig. 6A). This evidence concerns the gene ACP5 and juvenile polyposis syndrome.